JVLIX | VIVAX | JVLIX / VIVAX | |
Total Expense Ratio | 0.71 | 0.17 | 418% |
Annual Report Gross Expense Ratio | 0.72 | 0.17 | 424% |
Fund Existence | 29 years | 33 years | - |
Gain YTD | 8.998 | 6.724 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.1B | 195B | 9% |
Annual Yield % from dividends | 0.95 | 2.06 | 46% |
Returns for 1 year | 0.11 | 9.76 | 1% |
Returns for 3 years | 16.23 | 34.31 | 47% |
Returns for 5 years | 42.07 | 74.87 | 56% |
Returns for 10 years | 37.88 | 116.32 | 33% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MRNY | 2.52 | 0.02 | +0.80% |
YieldMax MRNA Option Income Strategy ETF | |||
IWMW | 39.53 | 0.14 | +0.34% |
iShares Russell 2000 BuyWrite ETF | |||
VBND | 43.33 | 0.04 | +0.08% |
Vident U.S. Bond Strategy ETF | |||
XT | 67.39 | N/A | N/A |
iShares Exponential Technologies ETF | |||
BNDS | 49.81 | -0.01 | -0.02% |
Infrastructure Capital Bond Income ETF |